|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1993; 22:1897-1901 © 1993 by the American College of Cardiology Foundation |
Department of Internal Medicine, University of Innsbruck, Austria.
OBJECTIVES. The purpose of this study was to examine the role of tumor necrosis factor-alpha and tetrahydrobiopterin and superoxide anion release from neutrophils in severe chronic heart failure. BACKGROUND. Previous studies have demonstrated elevated production of tumor necrosis factor-alpha and free radical-induced endothelial cell damage in severe heart failure. METHODS. Plasma and serum levels of immunoreactive interleukin-1, interleukin-6, interferon-gamma, neopterin and tumor necrosis factor-alpha and the release of superoxide anions from circulating neutrophils both at basal conditions and after triggering with f-Met-Leu-Phe or phorbol 12-myristate 13-acetate were measured in 16 patients with severe heart failure and in 11 healthy control subjects. RESULTS. Circulating levels of tumor necrosis factor-alpha and neopterin were elevated in patients with heart failure compared with values in control subjects. A significant correlation between the two was found. Basal and phorbolester-triggered release of oxygen radicals from neutrophils was not affected in patients with heart failure. However, formylpeptide-stimulated release of oxygen radicals by neutrophils was significantly reduced. CONCLUSIONS. Suppressed neutrophil function in patients with heart failure exhibiting elevated levels of tumor necrosis-alpha factor may indicate self-protection against the deleterious effects of neutrophil-derived oxygen radicals. Through induction of tetrahydrobiopterin synthesis (as reflected by increased neopterin), tumor necrosis factor-alpha may affect nitric oxide synthesis.
This article has been cited by other articles:
|
|
 |
|
  J. Barani, I. Mattiasson, B. Lindblad, and A. Gottsater Cardiac Function, Inflammatory Mediators and Mortality in Critical Limb Ischemia Angiology, August 1, 2006; 57(4): 437 - 444. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Ahokas, K. J. Warrington, I. C. Gerling, Y. Sun, L. A. Wodi, P. A. Herring, L. Lu, S. K. Bhattacharya, A. E. Postlethwaite, and K. T. Weber Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface Circ. Res., November 14, 2003; 93 (10): e124 - e135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Bradham, B. Bozkurt, H. Gunasinghe, D. Mann, and F. G. Spinale Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective Cardiovasc Res, March 1, 2002; 53(4): 822 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kell, A. Haunstetter, T.J. Dengler, C. Zugck, W. Kubler, and M. Haass Do cytokines enable risk stratification to be improved in NYHA functional class III patients?. Comparison with other potential predictors of prognosis Eur. Heart J., January 1, 2002; 23(1): 70 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.L. Clark, M. Loebe, E.V. Potapov, K. Egerer, C. Knosalla, R. Hetzer, and S.D. Anker Ventricular assist device in severe heart failure. Effects on cytokines, complement and body weight Eur. Heart J., December 2, 2001; 22(24): 2275 - 2283. [Abstract] [PDF]
|
|
|
|
 |
|
 C.-W. Kong, T.-G. Hsu, F.-J. Lu, W.-L. Chan, and K. Tsai Leukocyte mitochondria depolarization and apoptosis in advanced heart failure: clinical correlations and effect of therapy J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1693 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maeda, T. Tsutamoto, A. Wada, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, T. Matsumoto, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1587 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bozkurt Activation of cytokines as a mechanism of disease progression in heart failure Ann Rheum Dis, November 1, 2000; 59(90001): i90 - 93. [Full Text] [PDF]
|
|
|
|
|
|
A. Gottsater, I. Anwaar, K.-F. Eriksson, I. Mattiasson, F. Lindgarde, and A. Gottsater Homocysteine Is Related to Neopterin and Endothelin-1 in Plasma of Subjects with Disturbed Glucose Metabolism and Reference Subjects Angiology, June 1, 2000; 51(6): 489 - 497. [Abstract] [PDF]
|
|
|
|
|
|
C Berry and A.L Clark Catabolism in chronic heart failure Eur. Heart J., April 1, 2000; 21(7): 521 - 532. [PDF]
|
|
|
|
|
|
M Tendera and H Wysocki TNF-{alpha} in patients with chronic failure is not only a proinflammatory cytokine Eur. Heart J., October 2, 1999; 20(20): 1445 - 1446. [PDF]
|
|
|
|
|
|
Z. Dibbs, J. Thornby, B. G. White, and D. L. Mann Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Herrera-Garza, S. J. Stetson, A. Cubillos-Garzon, M. T. Vooletich, J. A. Farmer, and G. Torre-Amione Tumor Necrosis Factor-{alpha}: A Mediator of Disease Progression in the Failing Human Heart Chest, April 1, 1999; 115(4): 1170 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bozkurt, S. B. Kribbs, F. J. Clubb Jr, L. H. Michael, V. V. Didenko, P. J. Hornsby, Y. Seta, H. Oral, F. G. Spinale, and D. L. Mann Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-{alpha} Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats Circulation, April 14, 1998; 97(14): 1382 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ferrari Tumor necrosis factor in CHF: a double facet cytokine Cardiovasc Res, March 1, 1998; 37(3): 554 - 559. [Full Text] [PDF]
|
|
|
|
|
|
G. Torre-Amione, S. Kapadia, J. Lee, J.-B. Durand, R. D. Bies, J. B. Young, and D. L. Mann Tumor Necrosis Factor-{alpha} and Tumor Necrosis Factor Receptors in the Failing Human Heart Circulation, February 15, 1996; 93(4): 704 - 711. [Abstract] [Full Text]
|
|
|
|
|
|
M. Packer Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure? Circulation, September 15, 1995; 92(6): 1379 - 1382. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
